MedTrace Logo

PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"

NCT03187457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-12-13

No results posted yet for this study

Summary

The study will assess vaginal microbiota levels before and after antibiotic treatment in females infected with Bacterial Vaginosis (BV).

Conditions

  • Bacterial Vaginosis

Interventions

OTHER

Metronidazole

Women with Bacterial Vaginosis treated with Metronidazole for 5 days

OTHER

Control: no treatment

Healthy women without Bacterial Vaginosis

Sponsors & Collaborators

  • Community Pharmacology Services Ltd

    collaborator OTHER

  • Danisco

    lead INDUSTRY

Principal Investigators

  • Gordon Crawford, MD · CPS Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-04
Primary Completion
2017-11-14
Completion
2017-11-14

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03187457 on ClinicalTrials.gov